Panel Discussion: Evolving the Patient Engagement Paradigm in Rare Disease
Time: 4:30 pm
day: Day Two PM
- Outlining how all stakeholders stand to benefit from patient groups being involved throughout the drug development path
- How can drug developers ensure that the patient voice is never lost throughout the development process?
- Where in the drug development pathway are their further opportunities for drug developers to engage rare disease patient groups?
- Stories of successful patient engagement and potential areas for industry to improve on